Christine Murray

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.

M. Caligiuri, M. Ross, R. Soiffer, 1993, The Journal of clinical investigation.

Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation.

J. Ritz, R. Soiffer, J. Daley, 1992, Blood.

Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicity.

M. Caligiuri, R. Soiffer, M. Seiden, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.

C. Perreault, R. Gonin, G. Pichert, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation.

R. Soiffer, L. Nadler, J. Daley, 1993, Blood.

Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation.

J. Ritz, L. Bosserman, R. Soiffer, 1990, Blood.

Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.

A. Freedman, R. Soiffer, R. Gonin, 1993, Bone marrow transplantation.